Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions.
52W Range
21stpctl
Volume
0.28×avg
Market Cap
78.40MUSD
P/E Ratio
-0.8TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Telomir Pharmaceuticals, Inc. Common Stock
TELONASDAQ Capital Market·USD·Closed
Telomir Pharmaceuticals, Inc. Common Stock
TELONASDAQ·USD·Closed
$1.14
−4.20%
$1.14
−$0.05 (4.20%)
52W Range
21stpctl
Volume
0.28×avg
Mkt Cap
78.40MUSD
P/E
-0.8TTM
Div Yield
–ann
TELO: Telomir Pharmaceuticals, Inc. Common Stock Stock Analysis | finqOS
